SrasV1, PubMed, Curation, bibRecord, 001D48

Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Identifieur interne : 001D48 ( PubMed/Curation ); précédent : 001D47; suivant : 001D49

Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Auteurs : Daniel H. Libraty [États-Unis] ; Kimberly M. O'Neil ; Lauren M. Baker ; Luz P. Acosta ; Remigio M. Olveda

Source :

Virology [ 0042-6822 ] ; 2007.

RBID : pubmed:17692881

Descripteurs français

KwdFr :
- Convalescence, Humains, Interféron gamma (biosynthèse), Lignée cellulaire, Lymphocytes T CD4+ (immunologie), Mémoire immunologique (immunologie), Peptides (), Peptides (immunologie), Protéines virales structurales (), Protéines virales structurales (immunologie), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (virologie), Séquence d'acides aminés, Virus du SRAS (immunologie).
MESH :
- biosynthèse : Interféron gamma.
- immunologie : Lymphocytes T CD4+, Mémoire immunologique, Peptides, Protéines virales structurales, Syndrome respiratoire aigu sévère, Virus du SRAS.
- virologie : Syndrome respiratoire aigu sévère.
- Convalescence, Humains, Lignée cellulaire, Peptides, Protéines virales structurales, Séquence d'acides aminés.

English descriptors

KwdEn :
- Amino Acid Sequence, CD4-Positive T-Lymphocytes (immunology), Cell Line, Convalescence, Humans, Immunologic Memory (immunology), Interferon-gamma (biosynthesis), Peptides (chemistry), Peptides (immunology), SARS Virus (immunology), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (virology), Viral Structural Proteins (chemistry), Viral Structural Proteins (immunology).
MESH :
- chemical , biosynthesis : Interferon-gamma.
- chemical , chemistry : Peptides, Viral Structural Proteins.
- immunology : CD4-Positive T-Lymphocytes, Immunologic Memory, Peptides, SARS Virus, Severe Acute Respiratory Syndrome, Viral Structural Proteins.
- virology : Severe Acute Respiratory Syndrome.
- Amino Acid Sequence, Cell Line, Convalescence, Humans.

Abstract

Little is known about CD4(+) T-cell immunity to the severe acute respiratory syndrome (SARS) coronavirus. In two SARS patients, we examined the memory CD4(+) T-cell responses to peptides derived from SARS coronavirus structural proteins. We generated CD4(+) T-cell lines to 3 peptides from the spike (S) protein and defined their HLA restriction. In one patient, the predominant memory CD4(+) T-cell response was directed against an epitope outside the S protein receptor-binding domain. In both patients, the frequency of CD4(+) memory T-cells to virus structural proteins and anti-SARS coronavirus IgG levels were low by 12 months after infection. This report expands our understanding of the specificity and duration of anti-SARS coronavirus CD4(+) T-cell immune responses.

DOI: 10.1016/j.virol.2007.07.015
PubMed: 17692881

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001D48

Links to Exploration step

pubmed:17692881

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.</title>
<author><name sortKey="Libraty, Daniel H" sort="Libraty, Daniel H" uniqKey="Libraty D" first="Daniel H" last="Libraty">Daniel H. Libraty</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA. daniel.libraty@umassmed.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="O Neil, Kimberly M" sort="O Neil, Kimberly M" uniqKey="O Neil K" first="Kimberly M" last="O'Neil">Kimberly M. O'Neil</name>
</author>
<author><name sortKey="Baker, Lauren M" sort="Baker, Lauren M" uniqKey="Baker L" first="Lauren M" last="Baker">Lauren M. Baker</name>
</author>
<author><name sortKey="Acosta, Luz P" sort="Acosta, Luz P" uniqKey="Acosta L" first="Luz P" last="Acosta">Luz P. Acosta</name>
</author>
<author><name sortKey="Olveda, Remigio M" sort="Olveda, Remigio M" uniqKey="Olveda R" first="Remigio M" last="Olveda">Remigio M. Olveda</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17692881</idno>
<idno type="pmid">17692881</idno>
<idno type="doi">10.1016/j.virol.2007.07.015</idno>
<idno type="wicri:Area/PubMed/Corpus">001D48</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D48</idno>
<idno type="wicri:Area/PubMed/Curation">001D48</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D48</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.</title>
<author><name sortKey="Libraty, Daniel H" sort="Libraty, Daniel H" uniqKey="Libraty D" first="Daniel H" last="Libraty">Daniel H. Libraty</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA. daniel.libraty@umassmed.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="O Neil, Kimberly M" sort="O Neil, Kimberly M" uniqKey="O Neil K" first="Kimberly M" last="O'Neil">Kimberly M. O'Neil</name>
</author>
<author><name sortKey="Baker, Lauren M" sort="Baker, Lauren M" uniqKey="Baker L" first="Lauren M" last="Baker">Lauren M. Baker</name>
</author>
<author><name sortKey="Acosta, Luz P" sort="Acosta, Luz P" uniqKey="Acosta L" first="Luz P" last="Acosta">Luz P. Acosta</name>
</author>
<author><name sortKey="Olveda, Remigio M" sort="Olveda, Remigio M" uniqKey="Olveda R" first="Remigio M" last="Olveda">Remigio M. Olveda</name>
</author>
</analytic>
<series><title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>Cell Line</term>
<term>Convalescence</term>
<term>Humans</term>
<term>Immunologic Memory (immunology)</term>
<term>Interferon-gamma (biosynthesis)</term>
<term>Peptides (chemistry)</term>
<term>Peptides (immunology)</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Viral Structural Proteins (chemistry)</term>
<term>Viral Structural Proteins (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Convalescence</term>
<term>Humains</term>
<term>Interféron gamma (biosynthèse)</term>
<term>Lignée cellulaire</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Mémoire immunologique (immunologie)</term>
<term>Peptides ()</term>
<term>Peptides (immunologie)</term>
<term>Protéines virales structurales ()</term>
<term>Protéines virales structurales (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Interferon-gamma</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Peptides</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Interféron gamma</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T CD4+</term>
<term>Mémoire immunologique</term>
<term>Peptides</term>
<term>Protéines virales structurales</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>Immunologic Memory</term>
<term>Peptides</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Cell Line</term>
<term>Convalescence</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Convalescence</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Peptides</term>
<term>Protéines virales structurales</term>
<term>Séquence d'acides aminés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Little is known about CD4(+) T-cell immunity to the severe acute respiratory syndrome (SARS) coronavirus. In two SARS patients, we examined the memory CD4(+) T-cell responses to peptides derived from SARS coronavirus structural proteins. We generated CD4(+) T-cell lines to 3 peptides from the spike (S) protein and defined their HLA restriction. In one patient, the predominant memory CD4(+) T-cell response was directed against an epitope outside the S protein receptor-binding domain. In both patients, the frequency of CD4(+) memory T-cells to virus structural proteins and anti-SARS coronavirus IgG levels were low by 12 months after infection. This report expands our understanding of the specificity and duration of anti-SARS coronavirus CD4(+) T-cell immune responses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17692881</PMID>
<DateCompleted><Year>2007</Year>
<Month>12</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0042-6822</ISSN>
<JournalIssue CitedMedium="Print"><Volume>368</Volume>
<Issue>2</Issue>
<PubDate><Year>2007</Year>
<Month>Nov</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Virology</Title>
<ISOAbbreviation>Virology</ISOAbbreviation>
</Journal>
<ArticleTitle>Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.</ArticleTitle>
<Pagination><MedlinePgn>317-21</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Little is known about CD4(+) T-cell immunity to the severe acute respiratory syndrome (SARS) coronavirus. In two SARS patients, we examined the memory CD4(+) T-cell responses to peptides derived from SARS coronavirus structural proteins. We generated CD4(+) T-cell lines to 3 peptides from the spike (S) protein and defined their HLA restriction. In one patient, the predominant memory CD4(+) T-cell response was directed against an epitope outside the S protein receptor-binding domain. In both patients, the frequency of CD4(+) memory T-cells to virus structural proteins and anti-SARS coronavirus IgG levels were low by 12 months after infection. This report expands our understanding of the specificity and duration of anti-SARS coronavirus CD4(+) T-cell immune responses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Libraty</LastName>
<ForeName>Daniel H</ForeName>
<Initials>DH</Initials>
<AffiliationInfo><Affiliation>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA. daniel.libraty@umassmed.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>O'Neil</LastName>
<ForeName>Kimberly M</ForeName>
<Initials>KM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Baker</LastName>
<ForeName>Lauren M</ForeName>
<Initials>LM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Acosta</LastName>
<ForeName>Luz P</ForeName>
<Initials>LP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Olveda</LastName>
<ForeName>Remigio M</ForeName>
<Initials>RM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>U19 AI057319</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 AI060791-02</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 AI060791</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U19 AI57319</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 AI060791-01</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Virology</MedlineTA>
<NlmUniqueID>0110674</NlmUniqueID>
<ISSNLinking>0042-6822</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003289" MajorTopicYN="N">Convalescence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year>
<Month>04</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2007</Year>
<Month>05</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2007</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>12</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17692881</ArticleId>
<ArticleId IdType="pii">S0042-6822(07)00480-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.virol.2007.07.015</ArticleId>
<ArticleId IdType="pmc">PMC2094716</ArticleId>
<ArticleId IdType="mid">NIHMS34146</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Sep;74(18):8740-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10954576</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Immunol. 2006 Aug;120(2):171-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16781892</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioinformatics. 2001 Dec;17(12):1236-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11751237</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microbes Infect. 2006 Aug;8(9-10):2424-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16844400</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 Feb 15;191(4):507-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655773</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2006 Mar 1;193(5):685-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16453264</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2006 Aug 1;351(2):466-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16690096</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Immunogenetics. 1999 Nov;50(3-4):213-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10602881</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2006 Nov 10;281(45):34610-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16954221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2005 Apr 15;174(8):4908-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15814718</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol Methods. 2004 Jan;284(1-2):89-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14736419</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Wkly Epidemiol Rec. 2003 May 30;78(22):189-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12836452</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Nov;72(11):8682-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765409</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16166518</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Tissue Antigens. 2000 May;55(5):383-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10885559</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D48 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001D48 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:17692881
   |texte=   Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:17692881" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki